Importantly, compelling evidence indicates that chronic SIGMAR1 activation can improve the ventricular remodeling after myocardial infarction in rats and decrease the susceptibility to ventricular arrhythmia [15], suggesting that SIGMAR1 might relieve myocardial I/R injury. The gene discussed is SIGMAR1; the disease is Ventricular arrhythmia.